An official website of the United States government
These tables are also available in a printable version (PDF, 258 KB).
Please refer to your standard setter(s) for specific reporting requirements before using the Casefinding List.
Comprehensive ICD-10 Casefinding "Must Collect" Code List for Reportable Tumors (Effective Date: 1/1/2013)
| ICD-10 Code^ | Explanation of Code |
|---|---|
| B21._ | Human Immunodeficiency virus [HIV] disease with malignant neoplasms |
| C00._ – C97._ | Malignant neoplasms Note: Pilocytic/juvenile astrocytoma M-9421 moved from behavior /3 (malignant) to /1 (borderline malignancy) in ICD-O-3. However, SEER registries will CONTINUE to report these cases and code behavior as /3 (malignant). |
| D00._ - D09._ | In-situ neoplasms Note: Carcinoma in situ of the cervix (CIN III-8077/2) and Prostatic Intraepithelial Carcinoma (PIN III-8148/2) are not reportable. |
| D18.0 | Hemangioma, any site Note: Includes Hemangiomas of Brain, Other parts of nervous system and endocrine glands, which are reportable. |
| D18.1 | Lymphangioma, any site Note: Includes Lymphangiomas of Brain, Other parts of nervous system and endocrine glands, which are reportable. |
| D32._ | Benign neoplasm of meninges (cerebral, spinal and unspecified) |
| D33._ | Benign neoplasm of brain and other parts of central nervous system |
| D35.2 | Benign neoplasm of pituitary gland |
| D35.3 | Benign neoplasm of craniopharyngeal duct |
| D35.4 | Benign neoplasm of pineal gland |
| D42._ | Neoplasm of uncertain or unknown behavior of meninges |
| D43._ | Neoplasm of uncertain or unknown behavior of brain and central nervous system |
| D44.3 – D44.5 | Neoplasm of uncertain or unknown behavior of pituitary gland, craniopharyngeal duct and pineal gland |
| D45 | Polycythemia vera (9950/3) |
| D46._ | Myelodysplastic syndromes (9980, 9982, 9983, 9985, 9986, 9989, 9991, 9992) |
| D47.1 | Chronic myeloproliferative disease (9960/3, 9961/3, 9963/3) |
| D47.3 | Esssential (hemorrhagic) thrombocythemia (9962/3) |
| D47.7 | Other specified neoplasms of uncertain/unknown behavior of lymphoid, hematopoietic (9965/3, 9966/3, 9967/3, 9971/3, 9975/3, 9987/3) |
| D47.9 | Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified (9960/3, 9961/3, 9970/1, 9931/3) |
| D48.9 | Neoplasm of uncertain or unknown behavior, unspecified Note: Review code for uncertain behavior brain, CNS tumors and reportable benign endocrine glands |
| D76._ | Certain diseases involving lymphoreticular tissue and reticulohistiocytic system |
NOTE: Cases with these codes should be screened as registry time allows. These are neoplasm-related secondary conditions for which there should also be a primary diagnosis of a reportable neoplasm. Experience in the SEER registries has shown that using the supplementary list increases casefinding for benign brain and CNS, hematopoietic, and other reportable neoplasms.
Supplementary List: ICD-10 Code List to Screen for Cancer Cases Not Identified by Other Codes (Effective Date: 1/1/2013)
(This list is to be used to help identify cases that MAY be reportable to the cancer registry. This is not a list of reportable neoplasms or reportable terms)
| ICD-10 Code^ | Explanation of Code |
|---|---|
| B20._, B22 - B24 | Human immunodeficiency virus [HIV] disease with other diseases Note: Excludes HIV with malignancy (B21), see reportable list |
| B99 | Other infectious diseases (Human papillomavirus, Retrovirus-HTLV types I, II, 2 |
| D10._ - D31._, D34, D35.0, D35.1, D35.5 - D35.9, D36._ |
Benign neoplasms (see “must collect” list for reportable benign neoplasms) Note: Screen for incorrectly coded malignancies or reportable by agreement tumors Note: Borderline cystadenomas M-8442, 8451, 8462, 8472, 8473, of the ovaries moved from behavior /3 (malignant) to /1 (borderline malignancy) in ICD-O-3. SEER registries are not required to collect these cases for diagnoses made 1/1/2001 and after. However, cases diagnosed prior to 1/1/2001 should still be abstracted and reported to SEER. |
| D37._ – D41._ | Neoplasms of uncertain or unknown behavior (see “must collect” list for reportable neoplasms of uncertain or unknown behavior) Note: Screen for incorrectly coded malignancies or reportable by agreement tumors |
D44.0 - D44.2, D44.6 - D44.9 |
Neoplasm of uncertain or unknown behavior of other endocrine glands (see “must collect” list for D44.3-D44.5) Note: Screen for incorrectly coded malignancies or reportable by agreement tumors |
| D47.0 | Histiocytic and mast cell tumors of uncertain behavior |
| D47.2 | Monoclonal gammopathy Note: Screen for incorrectly coded Waldenstrom’s macroglobulinemia |
| D48._ | Neoplasms of uncertain or unknown behavior Note: Screen for incorrectly coded malignancies or reportable by agreement tumors |
| D60._ | Acquired pure red cell aplasia [erythroblastopenia] Note: Screen for anemia disorder related to neoplasm |
| D61.1 – D61.9 | Other aplastic anemias Note: Review for miscodes |
| D63.0 | Anemia in neoplastic disease |
| D64._ | Other anemias Note: Screen for anemia disorder related to neoplasm |
| D69.4 – D69.9 | Other thrombocytopenia Note: Screen for incorrectly coded thrombocythemia |
| D70 | Agranulocytosis Note: Screen for blood disorders due to neoplasm |
| D72.1 | Eosinophilia Note: This is the code for eosinophilia (9964/3). Not every case of eosinophilia is associated with a malignancy. Diagnosis must be “Hypereosonophilic syndrome” to be reportable. |
| D75.8 | Other specified diseases of blood and blood forming organs Note: This is the code for myelofibrosis (NOS) (9961/3). Not every case of myelofibrosis is associated with a malignancy. Review terms included in ICD-O-3 to determine if case is reportable. |
| D80.3 – D80.5 | Selective deficiency of immunoglobulin Note: Associated with lymphoproliferative disorders |
| D81.0 – D81.2 | Severe combined immunodeficiency [SCID] Note: Associated with lymphoproliferative disorders |
| D84.9 | Immunodeficiency, unspecified Note: Associated with lymphoproliferative disorders |
| D89._ | Other disorders involving the immune mechanism, not elsewhere classified Note: Review for miscodes |
| E13._ | Other specified diabetes mellitus Note: Includes diabetes with underlying malignancy |
| E31.9 | Polyglandular dysfunction, unspecified Note: This is the code for “multiple endocrine neoplasia (MEN) type IIA and IIB (rare familial cancer syndrome) “ |
| E88.0 | Disorders of plasma-protein metabolism, not elsewhere classified Note: Screen for incorrectly coded Waldenstrom’s macroglobulinemia |
| E88.8 | Other specified metabolic disorders Note: Includes Tumor lysis syndrome following antineoplastic drug |
| G31.8 | Other specified degenerative diseases of nervous system Note: Includes myelopathy in neoplastic disease |
| G52.8 |
Disorders of other specified cranial nerves Note: Includes myelopathy in neoplastic disease |
| G54.8 | Other nerve root and plexus disorders Note: Includes nerve root and plexus compressions in neoplastic disease |
| G62.8 | Other specified polyneuropathies Note: Includes polyneuropathy disorders in neoplastic disease |
| G70.8 | Other specified myoneural disorders Note: Includes Eaton-Lambert syndrome in neoplastic disease |
| G90.8 | Other disorders of autonomic nervous system Note: Includes myelopathy in neoplastic diseases |
| G91.8 | Other hydrocephalus Note: Includes hydrocephalus in neoplastic diseases |
| G96.8 | Other specified disorders of central nervous system Note: Includes neuropathy in neoplastic disease |
| J84.8 | Other specified interstitial pulmonary diseases Note: Includes Adult pulmonary Langerhans cell histiocytosis |
| J90 | Pleural effusion, not elsewhere classified Note: Includes malignant pleural effusion |
| J93.1 | Other spontaneous pneumothorax Note: Includes secondary spontaneous pneumothorax due to neoplasm |
| K62.8 | Other specified diseases of anus and rectum Includes: (AIN I, AIN II) |
| M12.8 | Other specific arthropathies, not elsewhere classified Note: Includes arthropathy in neoplastic disease |
| M62.8 | Other specified disorders of muscle Note: Includes disorders of muscles (due to) neoplasm |
| M84.4 | Pathologic fracture, not elsewhere classified Note: Includes fracture due to neoplasm |
| M89.8 | Other specified disorders of bone Note: Includes osteitis deformans in neoplastic disease |
| N42.8 | Other specified diseases of prostate Includes: (PIN I,PIN II) |
| N87._ | Dysplasia of cervix Includes: CIN I and CIN II |
| N89.0-N89.3 | Dysplasia of vagina Includes: VAIN I and VAIN II |
| N90.0-N90.3 | Dysplasia of vulva Includes: VIN I and VIN II |
| O01._ | Hydatidiform mole Note: This is a benign tumor that can become malignant. If malignant, it should be reported as Choriocarcinoma (9100/3) and will have a malignancy code in the C00- C97 range |
| O99.8 | Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium Note: Includes: malignant neoplasm complicating pregnancy, childbirth and the pueperium |
| Q85.0 | Neurofibromatosis (nonmalignant) (9540/1) Note: Neurofibromatosis by itself is not reportable, but it can lead to a reportable condition |
| Q90._ | Down’s syndrome Note: Screen for myeloid leukemia associated with Down’s Syndrome (9898/3) |
| R18 | Ascites Note: Includes malignant ascites |
| R52.9 | Pain, unspecified Note: Includes neoplasm related pain (acute, chronic); Cancer associated pain; Pain due to malignancy (primary/secondary); Tumor associated pain |
| R53 | Malaise and fatigue Note: Includes neoplasm related fatigue |
| R59._ | Enlarged lymph nodes Note: Screen for large B-cell lymphoma arising in HHV8-associated multicentric Castleman disease (9738/3) |
| R82.8 | Abnormal findings on cytological and histological examination of urine |
| R83.6, R83.7 | Abnormal findings on cytological and histological examination of cerebrospinal fluid |
| R84.6, R84.7 | Abnormal findings on cytological and histological examination of respiratory organs and thorax |
| R85.6, R85.7 | Abnormal findings on cytological and histological examination of digestive organs and abdominal cavity |
| R86.6, R86.7 | Abnormal findings on cytological and histological examination of male genital organs |
| R87.6, R87.7 | Abnormal findings on cytological and histological examination of female genital organs |
| R89.6, R89.7 | Abnormal findings on cytological and histological examination of other organs systems and tissues |
| R91 | Abnormal findings on diagnostic imaging of lung |
| R92 | Abnormal findings on diagnostic imaging of breast |
| Y42.1 | Other and unspecified hormone antagonists (poisoning) |
| Y42.6 | Adverse reaction to antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified |
| Y43.1 - Y43.4 | Adverse effects in therapeutic use, antineoplastic products or drugs |
| Y43.9 | Adverse effects in therapeutic use, primarily systemic agent, unspecified Note: Includes poisoning by primarily systemic and hematological agents |
| Y44.9 | Other and unspecified agents affecting blood constituents Note: Includes bloodstream infection due to central venous catheter |
| Y63.2 | Failure in dosage, overdose of radiation given during therapy Note: Includes adverse reaction to radiation (see also Y84.2) |
| Y81.2 | General and plastic surgery devices associated with adverse incidents-prosthetic and other implants, materials, and accessory devices Note: Includes complications due to breast prosthesis |
| Y83.0 | Surgical operation with transplant of whole organ Note: Includes complications of transplant |
| Y84.2 | Abnormal reaction, radiological procedure and radiotherapy Note: Includes adverse reaction to radiation |
| Y84.9 | Other medical procedures (abnormal reaction) Note: Includes infection due to central venous catheter (see code Y44.9 for bloodstream infection) |
The following codes are associated with the paraneoplastic syndrome. Paraneoplastic syndrome by itself is not cancer. It’s a disease or symptom that is the consequence of cancer but is not due to the local presence of cancer cells. A paraneoplastic syndrome may be the first sign of cancer. These codes have been removed from the supplemental list and are now in their own list.
| ICD-10 Code^ | Explanation of Code |
|---|---|
| E22.2 | Syndrome of inappropriate secretion of antidiuretic hormone |
| E34.0 | Carcinoid syndrome |
| E34.1 | Other hypersecretion of intestinal hormones |
| E34.8 | Other specified endocrine disorders |
| E83.5 | Disorders of calcium metabolism |
| G04.8 | Other encephalitis, myelitis, and encephalomyelitis |
| H55 | Nystagmus and other irregular eye movements |
| L10.8 | Other pemphigus |
| L30.4 | Erythrema intertrigo |
| L53.8 | Other specified erythematous conditions |
| L83 | Acanthosis nigricans |
| L88 | Pyoderma gangrenosum |
| L98.2 | Febrile neutrophilic dermatosis [Sweet] |
| M33.2 | Polymyositis |
| M33.9 | Dermatopolymyositis, unspecified |
^ World Health Organization. International Statistical Classification of Diseases and Related Health problems, Tenth Revision. Geneva: World Health Organization. 2007
